Bayer launches latest immunoassay system
its ADVIA family of automated clinical laboratory solutions, which
enable laboratories to rapidly perform a wide variety of
disease-specific tests which enhance the management of disease.
The aim of the ADVIA Centaur CP is to package Bayer's ADVIA Centaur Immunoassay System technology in a smaller footprint, providing smaller labs with a testing service without costly sample splitting and result collation. Available in a benchtop model with a footprint of only 43" x 29" (107 x 74 cm), the ADVIA Centaur CP offers up to 180 tests per hour and a 400-test walkaway capability. "The ADVIA Centaur CP enables the mid-size and specialty laboratory to make improvements in productivity by consolidating testing onto a single platform sized for their laboratory needs." said Tom Warekois, SVP of Global Strategic Marketing, Bayer Diagnostics. The complete menu of disease state assay groups available on the ADVIA Centaur CP includes therapeutic drug monitoring, cardiovascular, oncology, fertility, and infectious disease testing capabilities. "With the introduction of the ADVIA Centaur CP, to the mid-sized laboratory in the community hospital, IDN satellite or private facility, Bayer aims to offer more analytical platforms, more assays and improved connectivity and integration," said Tony Bihl, President, Bayer Diagnostics. The CP, with its chemistry counterpart, the ADVIA 1200 Clinical Chemistry System, works alongside Bayer's networking and data management solution, ADVIA CentraLink. This allows delivery of sample handling, connectivity and system functionality to provide an effective immunoassay and clinical chemistry solution.
